SCHEMBL6005645

SCHEMBL6005645

CCCCOC(=O)NCCN1CC2CN(CCCNc3ccc(C#N)cc3)CC(C1)O2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.46
MGLL Q99685 2/20 0.43
HRH2 P25021 6/20 0.39
HRH1 P35367 6/20 0.39
HRH3 Q9Y5N1 2/20 0.39
CCR3 P51677 1/20 0.39
PKM P14618 1/20 0.38
CACNA1B Q00975 2/20 0.38
CD274 Q9NZQ7 1/20 0.37
KCNA5 P22460 2/20 0.37
CACNA1H O95180 1/20 0.37
CACNA1F O60840 1/20 0.37
HTR1A P08908 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
DRD2 P14416 1/20 0.37
CNR1 P21554 1/20 0.37
DRD1 P21728 1/20 0.37
DRD4 P21917 1/20 0.37
DRD5 P21918 1/20 0.37
SLC6A2 P23975 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3126044 0.85 KCNH2 (0.45) KCNH2HRH3CCR3CD274DRD2
SCHEMBL2966847 0.83 KCNH2 (0.46) KCNH2CCR3PKMCD274DRD2
SCHEMBL2967483 0.81 KCNH2 (0.48) KCNH2HRH2HRH1HRH3CCR3
SCHEMBL2962910 0.80 KCNH2 (0.41) KCNH2HRH2HRH1HRH3CCR3
SCHEMBL2966214 0.80 KCNH2 (0.44) KCNH2HRH2HRH1CCR3PKM
SCHEMBL2967583 0.79 KCNH2 (0.45) KCNH2HRH2HRH1CCR3PKM
SCHEMBL2963123 0.79 KCNH2 (0.56) KCNH2HRH2HRH1HRH3CACNA1B
SCHEMBL2966852 0.79 KCNH2 (0.44) KCNH2HRH2HRH1CCR3KCNA5
SCHEMBL2961502 0.78 KCNH2 (0.46) KCNH2HRH2HRH1HRH3CCR3
SCHEMBL2961112 0.78 KCNH2 (0.43) KCNH2HRH2HRH1HRH3CCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389212-B1 3,7-DIAZABICYCLO 3.3.1| FORMULATIONS AS ANTI-ARRYTHMIC COMPOUNDS ASTRAZENECA AB (SE) 2006-07-12 EP disclosed
EP-1389212-A1 3,7-DIAZABICYCLO 3.3.1] FORMULATIONS AS ANTI-ARRYTHMIC COMPOUNDS AstraZeneca AB (SE) 2004-02-18 EP disclosed